Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
see.ip - Details for CRLX101 ZUR VERWENDUNG BEI DER KREBSBEHANDLUNG
Details for 2010817784
Up to date per 17.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2010817784
Title / Product Name
CRLX101 ZUR VERWENDUNG BEI DER KREBSBEHANDLUNG
Status
Deleted
Protection Type
European Patent
(AT-) Application Number
2010817784
EP Publication Number
2477985
E-Number
1061268
Language
EN
PCT Number
US10048973
Publication Date
25.07.2012 A
07.11.2018 B1
Registration Date
07.11.2018
AT Publication Date
15.11.2018
Application Date
15.09.2010
Registration Number
-
Priorities
15.09.2009
US
242752 P
24.03.2010
US
317039 P
06.05.2010
US
332150 P
10.09.2010
US
381851 P
IPC
A61K 31/724 20060101AFI20180326BHEP
Maximum Duration of Protection
15.09.2030
Owner
BlueLink Pharmaceuticals, Inc.
2503 S. Loop Drive, Ste 5100
Ames, Iowa 50010
US
Representative
No representatives present
Inventor
YEN, Yun
1301 Oaklawn Road
Arcadia, CA 91006
US
SCHLUEP, Thomas
3030 Hermosa Avenue
Las Cresenta, CA 91214
US
RYAN, John
26 W. Bells Mil Road
Philadelphia, PA 19118
US
DAVIS, Mark
575 Laguna Road
Pasadena, CA 91105
US
OLIVER, James, C.
4100 City of Oaks Wynd
Raleigh, NC 27612
US